首页> Open forum infectious diseases> Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.

导出 LinkOut

翻译打印收藏纠错

第一作者： James M,Crawford

第一单位： Northwell, Department of Pathology and Laboratory Medicine, New Hyde Park, New York, USA.

作者： James M,Crawford ^[1] ; Lynne,Penberthy ^[2] ; Ligia A,Pinto ^[3] ; Keri N,Althoff ^[4] ; Magdalene M,Assimon ^[5] ; Oren,Cohen ^[6] ; Laura,Gillim ^[6] ; Tracy L,Hammonds ^[7] ; Shilpa,Kapur ^[2] ; Harvey W,Kaufman ^[8] ; David,Kwasny ^[7] ; Jean W,Liew ^[9] ; William A,Meyer ^[8] ; Shannon L,Reynolds ^[5] ; Cheryl B,Schleicher ^[1] ; Suki,Subbiah ^[10] ; Catherine,Theruviparampil ^[5] ; Zachary S,Wallace ^[11] ; Jeremy L,Warner ^[12] ; Suhyeon,Yoon ^[13] ; Yonah C,Ziemba ^[1]

作者单位： Northwell, Department of Pathology and Laboratory Medicine, New Hyde Park, New York, USA. ^[1] Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. ^[2] Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA. ^[3] John Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland, USA. ^[4] Aetion Inc, New York, New York, USA. ^[5] Laboratory Corporation of America, Burlington, North Carolina, USA. ^[6] HealthVerity, Philadelphia, Pennsylvania, USA. ^[7] Quest Diagnostics, Secaucus, New Jersey, USA. ^[8] Boston University Chobanian and Avedisian School of Medicine, Section of Rheumatology, Boston, Massachusetts, USA. ^[9] Louisiana State University Health Sciences Center, Section of Hematology/Oncology, New Orleans, Louisiana, USA. ^[10] Massachusetts General Hospital, Division of Rheumatology, Allergy, and Immunology, Boston, Massachusetts, USA. ^[11] Brown University, Department of Medicine, Providence, Rhode Island, USA.;Rhode Island Hospital, Providence, Rhode Island, USA. ^[12] Integrated Data Sciences Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. ^[13]

关键词 SARS-CoV-2 SEER immunocompromised serology vaccination

DOI 10.1093/ofid/ofaf021

PMID 39850579

发布时间 2025-02-05

基金项目

75N91019D00024/CA/NCI NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Open forum infectious diseases

2025年12卷1期

ofaf021页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Open forum infectious diseases

2025年12卷1期

ofaf021页

检索历史清除

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.

Open forum infectious diseases

相似文献

同项目论文

Open forum infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.

Open forum infectious diseases

相似文献

同项目论文

Open forum infectious diseases

相关期刊

检索历史清除